Ratifi English Iniciar sesión
Ratifi

Proyectos federales de Congress.gov. Proyectos estatales de Open States.

A 1996Sesión 221

Qué cambió entre versiones

13 párrafos cambiaron+178 palabras agregadas−8 eliminadas

El texto resaltado se agregó en la versión más reciente. El texto tachado se eliminó.

[FirstSecond Reprint]

ASSEMBLY, No. 1996

8 párrafos sin cambios

STATE OF NEW JERSEY

221st LEGISLATURE

PRE-FILED FOR INTRODUCTION IN THE 2024 SESSION

Sponsored by:

Assemblywoman SHANIQUE SPEIGHT

District 29 (Essex and Hudson)

Assemblywoman VERLINA REYNOLDS-JACKSON

District 15 (Hunterdon and Mercer)

Co-Sponsored by:

Assemblywomen Peterpaul, Donlon, N.Munoz, Assemblymen Tully, Karabinchak and AssemblymanAssemblywoman TullyHall

SYNOPSIS

Establishes requirements to screenevaluate certain people who are pregnant and who have given birth for preeclampsia.

CURRENT VERSION OF TEXT

As reported by the Assembly HealthAppropriations Committee on DecemberMay 1615, 20242025, with amendments.

An Act concerning preeclampsia 2 [ screenings ] evaluations 2 and supplementing Title 26 of the Revised Statutes.

Be It Enacted by the Senate and General Assembly of the State of New Jersey:

1. a. 1 [ The Commissioner of Health shall require every ] Every 1 2 [ hospital 1 [ in the State, every ] or 1 ] 2 birthing center licensed in the State pursuant to P.L.1971, c.136 (C.26:2H-1 et seq.), every federally qualified health center, and every 2 licensed 2 1 [ physician or ] 1 health care practitioner 2 [ in the State ] 2 providing 2 prenatal 2 care to a pregnant person 2 , 2 or 2 postpartum care 2 1 to 1 a person who 2 [ has given ] seeks treatment within 12 weeks of giving 2 birth 2 [ 1 within the prior 12 weeks 1 ] 2 , 1 [ to screen ] shall adopt and adhere to policies requiring 1 the person 1 to be 2 [ screened 1 ] evaluated, as necessary, 2 for 1 [ preeclampsia ] hypertensive disorders related to pregnancy, including, but not limited to, postpartum preeclampsia and hypertension, 1 if the person shows symptoms of the condition 1 and has not in the current or recent pregnancy previously been diagnosed with the condition or after the onset of such symptoms 1 . 2 [ Screening ] Evaluation 2 tools shall be based on 1 [ industry ] 1 best practices and guidance, as determined by the American College of Obstetricians and Gynecologists or another nationally-recognized body 2 [ as may be designated by the 1 [ commissioner ] Commissioner of Health, in consultation with the State Board of Medical Examiners 1 ] 2 .

b. 2 [ A 1 licensed 1 hospital 1 [ , a licensed ] or 1 ] Every 2 birthing center 2 licensed in the State pursuant to P.L.1971, c.136 (C.26:2H-1 et seq.) 2 , 2 [ or a ] every 2 federally qualified health center 2 [ providing care to ] 2 , 2 [ or a ] 2 1 [ physician or other ] 1 2 and every licensed 2 health care practitioner 2 [ who is the primary caregiver for, ] providing prenatal care to 2 a pregnant person 2 , 2 or 2 postpartum care to 2 a person who seeks treatment within 1 [ six ] 12 1 weeks of giving birth, shall, in accordance with 1 [ guidelines ] 2 [ policies 1 developed 1 [ by the commissioner ] pursuant to this act 1 ] nationally recognized evidence-based treatment practices 2 :

(1) provide the person with 2 evidence-based 2 information on 1 [ preeclampsia ] hypertensive disorders related to pregnancy preeclampsia, including, but not limited to, postpartum preeclampsia and hypertension 1 and potential warning signs and symptoms 2 [ through the educational 1 [ program ] information 1 developed pursuant subsection d. of this section ] 2 ;

(2) inform the person of the benefits of being 2 [ screened ] evaluated 2 for 1 [ preeclampsia ] hypertensive disorders related to pregnancy preeclampsia, including, but not limited to, postpartum preeclampsia and hypertension, 1 if the person shows symptoms of 1 [ the condition ] any such disorders 1 , and that the person 1 [ is required to ] should 1 be 2 [ screened ] evaluated 2 for 1 [ preeclampsia ] hypertensive disorders related to pregnancy under the circumstances set forth in this 2 [ act 1 ] section 2 unless the person 1 [ issues a written refusal ] declines 1 to be 2 [ screened ] evaluated 2 1 [ , which refusal shall be provided on a form and in a manner prescribed by the commissioner consistent with the provisions of subsection c. of this section ] 1 ;

1 [ (3) screen the person for preeclampsia unless the person provides written refusal as provided in paragraph (2) of this subsection. The person shall, on the form and in a manner prescribed by the commissioner consistent with subsection c. of this section, acknowledge receipt of the information provided by the hospital, birthing center, federally qualified health center, physician, or health care practitioner, as applicable, regarding the benefits of being screened for preeclampsia; ] 1 and

1 [ (4) encourage ] 2 [ (3) inform 1 the person 1 [ to ] of the benefits of 1 routinely 1 [ engage ] engaging 1 in home blood pressure monitoring 1 and encourage the person to do so 1 .

1 [ c. The commissioner shall develop a standardized form to be used for the purposes of providing the acknowledgement required pursuant to paragraph (3) of subsection b. of this section, which may also be used to provide written refusal to undergo a screening for preeclampsia pursuant to paragraph (2) of subsection b. of this section, if applicable hypertensive disorders related to pregnancy preeclampsia, including but not limited to postpartum preeclampsia and hypertension. ] 1

1 [ d. ] c. 1 The commissioner shall 1 [ develop ] 1 , in consultation with the 1 [ Preeclampsia Foundation and any other community-based organization as may be designated by the commissioner ] State Board of Medical Examiners 1 , 1 [ a preeclampsia ] develop 1 educational 1 [ program ] information concerning hypertensive disorders related to pregnancy, including, but not limited to, postpartum preeclampsia and hypertension 1 for pregnant individuals and individuals who have recently given birth. The educational 1 [ program ] information 1 shall include information on 1 [ preeclampsia ] hypertensive disorders related to pregnancy preeclampsia, including, but not limited to, postpartum preeclampsia and hypertension 1 and the potential warning signs and symptoms 1 [ of preeclampsia ] thereof 1 . 1 The educational information shall be distributed by the Department of Health to hospitals, birthing centers, federally qualified health centers, and health care practitioners that are subject to the provisions of this act. 1 ] 2

1 [ e. Upon receipt of the results of any screening conducted pursuant to subsection a. of this section, the hospital, licensed or birthing center, federally qualified health center, or physician or health care practitioner, as applicable, shall discuss the results with the person and, if the person has a positive screening for preeclampsia, develop a treatment plan to minimize the person’s risk from preeclampsia. ] 1

2 (3) upon receipt of the results of any evaluation conducted pursuant to this section, discuss the results with the person and, if the person has a positive evaluation for preeclampsia, develop an evidence-based treatment plan to minimize the person’s risk from preeclampsia. 2

2. The Commissioner of Health 1 [ , pursuant to the "Administrative Procedure Act," P.L.1968, c.410 (C.52:14B-1 et seq.), shall ] may 1 adopt rules and regulations 1 , in accordance with the “Administrative Procedure Act,” P.L.1968, c.410 (C.52:14B-1 et seq.), as are necessary 1 to effectuate the purposes of this act 1 , and the State Board of Medical Examiners, and any other agency or board that regulates health care practitioners subject to the requirements of section 1 of this act, shall promulgate rules and regulations as are necessary to effectuate the purposes of this act 1 .

3. This act shall take effect 2 [ immediately ] 180 days following enactment 2 .

Volver al texto completo